IMVT:NASDAQ
Immunovant Inc
$33.17
arrow_downward
-0.12%(-0.040) 1D
$33.17
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 18, 4:00:01 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMVT...
Open
$33.07
High
$34.23
Low
$32.59
Mkt. cap
6.86B
Avg. vol.
1.46M
Volume
907.61K
52-wk high
$45.35
52-wk low
$21.86
EPS
-$2.55
Beta
0.95
Shares outstanding
206.95M
No. of employees
315
Open
$33.07
High
$34.23
Low
$32.59
Mkt. cap
6.86B
Avg. vol.
1.46M
Volume
907.61K
52-wk high
$45.35
52-wk low
$21.86
EPS
-$2.55
Beta
0.95
Shares outstanding
206.95M
No. of employees
315
News stories
From web sources and news partners
About Immunovant Inc
Analyst ratings
Based on 9 analysts giving stock ratings to IMVT in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for IMVT in the last 3 months.
Highest
Current $33.17
$66.00 (+98.97%)
Average
$45.78 (+38.02%)
Lowest
$33.00 (-0.51%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Brian Cheng J.P. Morgan | Buy | Maintained | $49.00 | +47.7% | 11/12/2026 |
Danielle Brill Truist Financial | Hold | Maintained | $33.00 | -0.5% | 11/10/2026 |
Douglas Tsao H.C. Wainwright | Buy | Reiterated | $41.00 | +23.6% | 11/10/2026 |
Derek Archila Wells Fargo | Buy | Reiterated | $47.00 | +41.7% | 11/10/2026 |
Dina Ramadane Bank of America Securities | Buy | Reiterated | $46.00 | +38.7% | 11/09/2026 |
Sam Slutsky LifeSci Capital | Buy | Maintained | $53.00 | +59.8% | 09/26/2026 |
Eve Burstein Bernstein | Hold | Maintained | $37.00 | +11.5% | 09/25/2026 |
Yasmeen Rahimi Piper Sandler | Buy | Maintained | $66.00 | +99% | 09/21/2026 |
Unknown Analyst UBS | Hold | Reiterated | $40.00 | +20.6% | 08/24/2026 |
Alex Thompson CFA Stifel Nicolaus | Buy | Maintained | $57.00 | +71.8% | 08/11/2026 |
Leland Gershell Oppenheimer | Buy | Reiterated | $54.00 | +62.8% | 08/07/2026 |
Samantha Semenkow Citi | Buy | Maintained | $61.00 | +83.9% | 06/30/2026 |
Yatin Suneja Guggenheim | Buy | Maintained | $62.00 | +86.9% | 05/26/2026 |
Jason Gerberry Bank of America Securities | Buy | Maintained | $43.00 | +29.6% | 05/21/2026 |
Corinne Johnson Goldman Sachs | Hold | Reiterated | $32.00 | -3.5% | 04/15/2026 |
Andy Chen Wolfe Research | Buy | Maintained | $47.00 | +41.7% | 04/06/2026 |
Thomas Smith Leerink Partners | Buy | Reiterated | $50.00 | +50.7% | 04/02/2026 |
Unknown Analyst Wells Fargo | Buy | Maintained | $45.00 | +35.7% | 04/01/2026 |
William Pickering Bernstein | Hold | Initiated | $28.00 | -15.6% | 03/20/2026 |
Last report
Nov 9, 2026
Fiscal period
Q2 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
-$0.41 / -$0.72
+43.78%beat
arrow_upward
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | - | - | - | - |
Cost of goods sold | - | - | - | - |
Cost of revenue | - | - | - | - |
Research and development expenses | 98.92M | 142.29M | 142.63M | 85.01M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 15.44M | 17.27M | 17.69M | 19.14M |
Operating expense | 114.36M | 159.55M | 160.32M | 104.16M |
Total operating expenses | 114.36M | 159.55M | 160.32M | 104.16M |
Operating income | -114.36M | -159.55M | -160.32M | -104.16M |
Other non operating income | -54.00K | 798.00K | 4.00K | 12.00K |
EBT including unusual items | -109.08M | -150.70M | -153.22M | -97.25M |
EBT excluding unusual items | -109.08M | -150.70M | -153.22M | -97.25M |
Income tax expense | 1.55M | -2.84M | - | - |
Effective tax rate | -1.42% | 1.89% | - | - |
Other operating expenses | - | - | - | - |
Net income | -110.64M | -147.86M | -153.22M | -97.25M |
Net profit margin | - | - | - | - |
Earnings per share | -0.54 | -0.67 | -0.68 | -0.41 |
Interest and investment income | 5.33M | 8.06M | 7.10M | 6.90M |
Interest expense | - | - | - | - |
Net interest expenses | 5.33M | 8.06M | 7.10M | 6.90M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | -114.26M | -159.46M | -160.23M | -104.07M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events